www.fdanews.com/articles/108887-stereotaxis-biosense-conclude-18-million-financial-arrangement
Stereotaxis, Biosense Conclude $18 Million Financial Arrangement
July 25, 2008
Stereotaxis, Inc., announced that it has amended its collaboration with Biosense Webster, Inc., Stereotaxis’ partner in the development of ablation catheters used with its Niobe Magnetic Navigation System.
iStockAnalyst
iStockAnalyst